Speaker: Charikleia Vrettou, MD, PhD, MRCP, EDIC, Consultant Intensivist, Evangelismos General Hospital, Athens, Greece
During this presentation, the speaker will provide insights into the clinical utility of the T2Bacteria and T2Resistance Panels in the intensive care unit (ICU), including real-world clinical case studies. They will also detail the results of a recently published observational study on the diagnostic accuracy of the T2MR assays in the ICU.
Learning Objectives
- Describe the clinical utility of the T2Bacteria and T2Resistance Panels in the ICU
- Demonstrate the accuracy of T2MR assays as point-of-care tests
- Discuss real-world clinical cases on panel application in the severely ill population
Watch the webinar by visiting Labroots.
*T2Resistance has not yet been reviewed by the FDA for clearance but is commercially available outside of the United States as a CE-marked product
